French food giant in focus as regulators weigh deals and health policy shifts
Danone has filed a lawsuit in Manhattan federal court alleging Chobani inflates protein claims on multiple-serving tubs of Chobani 20G Protein, a rival to Danone’s Oikos Pro. The case underscores how protein claims are shaping competition in the US amid rising GLP-1 weight-loss drug use. Danone says Chobani’s labeling misleads consumers and undercuts its pricing. Chobani rejects the allegations; analysts note concerns over capacity and competitive dynamics.
A coalition including supermarkets, charities and farming bodies warns the UK food system faces future shocks as production falls and imports rise. They call for a legally binding Good Food Bill to improve national food security, nutrition and resilience, citing higher prices, climate risks and biodiversity loss.
Northern Ireland is considering measures to curb obesity by restricting where unhealthy foods are placed in shops and online, mirroring policies in England and Wales. The Department of Health and the FSA have launched a consultation, arguing that price, placement and marketing influence purchases and contribute to obesity. Critics warn about effects on low-income families.
The CMA has cleared the €1bn Danone acquisition of Huel after a preliminary inquiry, with Danone saying the move will help growth in nutrition and international expansion for Huel. The deal values Huel at around €1bn and follows a series of branding and regulatory notes, including prior advertising scrutiny.